Brief: Asit Biotech H1 net loss widens to 7.5 million euros

European Medical Solutions SA

23/09/2016 17:01

Sept 23 (Reuters) - Asit Biotech Sa  ASIT.BR : 
    * No revenue in H1 versus 3,000 euros a year ago 
    * H1 operating loss of of 7.4 million euros versus loss of 
3.2 million euros a year ago 
    * H1 net loss of 7.5 million euros versus loss of 3.2 
million euros a year ago 
    * Cash position of 19 million euros at end-june 2016, 
following funds raised through its IPO 
    * Intends to continue preclinical and clinical development 
of its drug candidates in accordance with planned schedule. 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw7H2sdVa 
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))